BXRXQ

0.00010.00%
GA

Geraldine A. Henwood

President, CEO & Director

Dr. Geraldine A. Henwood Ph.D, also known as Gerri, is Director of Life Sciences Pennsylvania. Dr. Henwood has been the President, Chief Executive Officer and Director of Baudax Bio Inc. since 2019. She has been the Chief Development Officer of Iomab-B at Actinium Pharmaceuticals, Inc. since September 2012. She has been the Chief Executive Officer of Garnet Biotherapeutics, Inc. since November 2008. She served as the Chief Executive Officer and President of Societal CDMO Inc(f/k/a Recro Pharma, Inc.) since 2008 until December 15, 2020 and served as its Director since 2008 until January 18, 2022. She is a Venture Partner at SCP Vitalife. She is the Founder of Malvern Consulting Group and served as its President from 2006 to 2013. She has experience in product commercialization, clinical development and regulatory approval processes. She founded Auxilium Pharmaceuticals Inc. and served as its Chairman of the Board from July 1999 to April 2005, Chief Executive Officer from July 1999 to July 17, 2006, President from July 1999 to May 2004 and Interim President from March 2005 to July 17, 2006. She served as a Consultant at Auxilium Pharmaceuticals Inc. since July 17, 2006. She served as the Chief Executive Officer and President of Theorem Clinical Research, Inc., since April 1994. From 1985 to 1999, she served as the Chief Executive Officer at IBAH, which she founded in 1985. Prior to that, she served as Group Director of Marketing in the International Pharmaceutical Division at Smith Kline & French Laboratories, part of Glaxo SmithKline PLC. From April 1994 to 1999, she served as the President and Chief Executive Officer of Omnicare Clinical Research, Inc. Prior to that, she served in a variety of marketing, senior medical and regulatory positions at Smith Kline & French Laboratories. She began her career with Smith Kline & French, now part of GlaxoSmithKline plc in the Pharmaceutical Marketing Department. She serves as Director of Seachaid Pharmaceuticals, Inc. She serves as a Director of Antler Science Two Ltd. She had been a Director of Tetraphase Pharmaceuticals, Inc. since April 15, 2015 until July 28, 2020. She served as a Director of Alkermes, Inc. from 2003 to March 2015. She is a Director of Garnet Biotherapeutics Inc since November 2008. She served as a Director of Alkermes plc from September 16, 2011 to March 7, 2015. She served as a Director of Omnicare Clinical Research, Inc. She served as a Director of Auxilium Pharmaceuticals Inc. since July 1999 until 2006. She served as a Director of Genomics Collaborative, Inc. She served as a Director of Theorem Clinical Research, Inc., since July 1992. She served as a Director of MAP Pharmaceuticals, Inc. from June 2004 to March 1, 2013. She serves on the Board of Trustees of LaSalle Academy. She holds a B.S. in Biology from Neuman College. She also holds a Ph.D.Chih-I Tai serves as Representative Director of Roo Hsing Co., Ltd since January 21, 2022. Chih-I Tai has served as Director and Chief Financial Officer of First Steamship Co., Ltd. and Grand Ocean Retail Group Limited.

Positions